Zachary Jackson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zachary Jackson has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Joshua Busken
Edison Biotechnology Institute, Konneker Research Labs , Athens, Ohio 45701 , USA
3 shared publications- Darlene E. Berryman
Institute for Molecular Medicine and Aging, Heritage College of Osteopathic Medicine Ohio University Athens Ohio USA
2 shared publications - Edward Owen List
Edison Biotechnology Institute and Heritage College of Osteopathic Medicine, Ohio University , Athens, OH 45701
2 shared publications - Elizabeth A. Jensen
Translational Biomedical Sciences Graduate Program, Graduate College, Ohio University , Athens, Ohio 45701 , USA
2 shared publications - Erin R. Murphy
Ohio University Heritage College of Osteopathic Medicine
2 shared publications Jaycie Kuhn
Edison Biotechnology Institute, Konneker Research Labs , Athens, Ohio 45701 , USA
2 shared publications
Latest Publications
- Open Access
- 25 May 2022
- Published by The Endocrine Society in Endocrinology
- Vol. 163 (7)
Excess Growth Hormone Alters the Male Mouse Gut Microbiome in an Age-dependent Manner
The gut microbiome has an important role in host development, metabolism, growth, and aging. Recent research points toward potential crosstalk between the gut microbiota and the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis. Our laboratory previously showed that GH excess and deficiency are associated with an altered gut microbial composition in adult mice. Yet, no study to date has examined the influence of GH on the gut microbiome over time. Our study thus tracked the effect of excess GH action on the longitudinal changes in the gut microbial profile (ie, abundance, diversity/maturity, predictive metabolic function, and short-chain fatty acid [SCFA] levels) of bovine GH (bGH) transgenic mice at age 3, 6, and 12 months compared to littermate controls in the context of metabolism, intestinal phenotype, and premature aging. The bGH mice displayed age-dependent changes in microbial abundance, richness, and evenness. Microbial maturity was significantly explained by genotype and age. Moreover, several bacteria (ie, Lactobacillus, Lachnospiraceae, Bifidobacterium, and Faecalibaculum), predictive metabolic pathways (such as SCFA, vitamin B12, folate, menaquinol, peptidoglycan, and heme B biosynthesis), and SCFA levels (acetate, butyrate, lactate, and propionate) were consistently altered across all 3 time points, differentiating the longitudinal bGH microbiome from controls. Of note, the bGH mice also had significantly impaired intestinal fat absorption with increased fecal output. Collectively, these findings suggest that excess GH alters the gut microbiome in an age-dependent manner with distinct longitudinal microbial and predicted metabolic pathway signatures.
- 25 May 2022
- Published by The Endocrine Society in Endocrinology
- Vol. 163 (7)
Open AccessExcess Growth Hormone Alters the Male Mouse Gut Microbiome in an Age-dependent Manner
The gut microbiome has an important role in host development, metabolism, growth, and aging. Recent research points toward potential crosstalk between the gut microbiota and the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis. Our laboratory previously showed that GH excess and deficiency are associated with an altered gut microbial composition in adult mice. Yet, no study to date has examined the influence of GH on the gut microbiome over time. Our study thus tracked the effect of excess GH action on the longitudinal changes in the gut microbial profile (ie, abundance, diversity/maturity, predictive metabolic function, and short-chain fatty acid [SCFA] levels) of bovine GH (bGH) transgenic mice at age 3, 6, and 12 months compared to littermate controls in the context of metabolism, intestinal phenotype, and premature aging. The bGH mice displayed age-dependent changes in microbial abundance, richness, and evenness. Microbial maturity was significantly explained by genotype and age. Moreover, several bacteria (ie, Lactobacillus, Lachnospiraceae, Bifidobacterium, and Faecalibaculum), predictive metabolic pathways (such as SCFA, vitamin B12, folate, menaquinol, peptidoglycan, and heme B biosynthesis), and SCFA levels (acetate, butyrate, lactate, and propionate) were consistently altered across all 3 time points, differentiating the longitudinal bGH microbiome from controls. Of note, the bGH mice also had significantly impaired intestinal fat absorption with increased fecal output. Collectively, these findings suggest that excess GH alters the gut microbiome in an age-dependent manner with distinct longitudinal microbial and predicted metabolic pathway signatures.
- Open Access
- 1 April 2020
- Published by The Endocrine Society in Endocrinology
- Vol. 161 (4)
Growth Hormone Deficiency and Excess Alter the Gut Microbiome in Adult Male Mice
The gut microbiome has been implicated in host metabolism, endocrinology, and pathophysiology. Furthermore, several studies have shown that gut bacteria impact host growth, partially mediated through the growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis. Yet, no study to date has examined the specific role of GH on the gut microbiome. Our study thus characterized the adult gut microbial profile and intestinal phenotype in GH gene-disrupted (GH-/-) mice (a model of GH deficiency) and bovine GH transgenic (bGH) mice (a model of chronic, excess GH action) at 6 months of age. Both the GH-/- and bGH mice had altered microbial signatures, in opposing directions at the phylum and genus levels. For example, GH-/- mice had significantly reduced abundance in the Proteobacteria, Campylobacterota, and Actinobacteria phyla, whereas bGH mice exhibited a trending increase in those phyla compared with respective controls. Analysis of maturity of the microbial community demonstrated that lack of GH results in a significantly more immature microbiome while excess GH increases microbial maturity. Several common bacterial genera were shared, although in opposing directions, between the 2 mouse lines (e.g., decreased in GH-/- mice and increased in bGH mice), suggesting an association with GH. Similarly, metabolic pathways like acetate, butyrate, heme B, and folate biosynthesis were predicted to be impacted by GH. This study is the first to characterize the gut microbiome in mouse lines with altered GH action and indicates that GH may play a role in the growth of certain microbiota thus impacting microbial maturation and metabolic function.
- 1 April 2020
- Published by The Endocrine Society in Endocrinology
- Vol. 161 (4)
Open AccessGrowth Hormone Deficiency and Excess Alter the Gut Microbiome in Adult Male Mice
The gut microbiome has been implicated in host metabolism, endocrinology, and pathophysiology. Furthermore, several studies have shown that gut bacteria impact host growth, partially mediated through the growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis. Yet, no study to date has examined the specific role of GH on the gut microbiome. Our study thus characterized the adult gut microbial profile and intestinal phenotype in GH gene-disrupted (GH-/-) mice (a model of GH deficiency) and bovine GH transgenic (bGH) mice (a model of chronic, excess GH action) at 6 months of age. Both the GH-/- and bGH mice had altered microbial signatures, in opposing directions at the phylum and genus levels. For example, GH-/- mice had significantly reduced abundance in the Proteobacteria, Campylobacterota, and Actinobacteria phyla, whereas bGH mice exhibited a trending increase in those phyla compared with respective controls. Analysis of maturity of the microbial community demonstrated that lack of GH results in a significantly more immature microbiome while excess GH increases microbial maturity. Several common bacterial genera were shared, although in opposing directions, between the 2 mouse lines (e.g., decreased in GH-/- mice and increased in bGH mice), suggesting an association with GH. Similarly, metabolic pathways like acetate, butyrate, heme B, and folate biosynthesis were predicted to be impacted by GH. This study is the first to characterize the gut microbiome in mouse lines with altered GH action and indicates that GH may play a role in the growth of certain microbiota thus impacting microbial maturation and metabolic function.
- Open Access
- 15 April 2019
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 3 (Supplement)
MON-473 Growth Hormone (GH) Impacts the Gut Microbial Profile: the Presence of Unique Bacterial Genera in Mouse Lines with Altered GH Action
Several recent studies have shown that gut microbiota can regulate the growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis, or specifically modulate endocrine IGF-1. Yet, the impact of GH on the gut microbiome has not been evaluated. This study characterized the fecal microbial profile in GH gene disrupted (GH-/-) mice and bovine GH transgenic (bGH) mice at 6 months of age compared to their respective littermate controls. Microbial abundance and diversity were quantified from fecal pellets of these four groups through 16S rRNA sequencing. Additional bioinformatics analyses assessed the unique microbial signature and predictive biological function of the microbiome. Both GH-/- and bGH mice exhibited a unique microbial profile. In terms of microbial abundance, GH-/- and bGH mice resulted in a similar significant shift in the ratio of Firmicutes to Bacteroidetes. However, GH-/- and bGH mice differed in abundance of the Proteobacteria and Epsilonbacteraeota phyla with a significant reduction in abundance in GH-/- mice and significantly increased abundance in bGH mice. The GH-/- microbiome exhibited a distinct microbial signature with microbial immaturity and a predictive biological function associated with increased carbohydrate metabolism and decreased antimicrobial synthesis. The bGH microbiome also had a unique microbial signature with increased microbial richness and evenness. Moreover, both mouse lines shared common bacterial candidates. Common bacterial genera like Turicibacter, Ruminococcaceae and Faecalibaculum had similar abundance profiles in the bGH mice and GH-/- mice (i.e. either upregulated or downregulated with both increased and decreased GH action). Interestingly, however, other bacteria, such as Parasutterella, Lachnospiraceae and Rikenellaceae, followed opposite trends between bGH and GH-/- mice (i.e. upregulated with increased GH action and downregulated with decreased GH action). Collectively, these results demonstrate that GH - in both states of excess and deficiency - yields a distinct microbial profile, including microbial abundance, diversity and potential function. More importantly, the common bacterial candidates like Parasutterella suggest that GH action influences the presence of certain gut microbiota. Additional studies will be conducted to further explore these unique GH-associated bacterial candidates and their impact on metabolic and intestinal health of the host. This work was partially funded by the John J. Kopchick Molecular and Cellular Biology/Translational Biomedical Sciences Research Fellowship, the Osteopathic Heritage Foundation, Dual Degree Program at Ohio University Heritage College of Osteopathic Medicine and the Mouse Metabolic Phenotyping Center at University of California, Davis (NIH grant U240DK092993).
- 15 April 2019
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 3 (Supplement)
Open AccessMON-473 Growth Hormone (GH) Impacts the Gut Microbial Profile: the Presence of Unique Bacterial Genera in Mouse Lines with Altered GH Action
Several recent studies have shown that gut microbiota can regulate the growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis, or specifically modulate endocrine IGF-1. Yet, the impact of GH on the gut microbiome has not been evaluated. This study characterized the fecal microbial profile in GH gene disrupted (GH-/-) mice and bovine GH transgenic (bGH) mice at 6 months of age compared to their respective littermate controls. Microbial abundance and diversity were quantified from fecal pellets of these four groups through 16S rRNA sequencing. Additional bioinformatics analyses assessed the unique microbial signature and predictive biological function of the microbiome. Both GH-/- and bGH mice exhibited a unique microbial profile. In terms of microbial abundance, GH-/- and bGH mice resulted in a similar significant shift in the ratio of Firmicutes to Bacteroidetes. However, GH-/- and bGH mice differed in abundance of the Proteobacteria and Epsilonbacteraeota phyla with a significant reduction in abundance in GH-/- mice and significantly increased abundance in bGH mice. The GH-/- microbiome exhibited a distinct microbial signature with microbial immaturity and a predictive biological function associated with increased carbohydrate metabolism and decreased antimicrobial synthesis. The bGH microbiome also had a unique microbial signature with increased microbial richness and evenness. Moreover, both mouse lines shared common bacterial candidates. Common bacterial genera like Turicibacter, Ruminococcaceae and Faecalibaculum had similar abundance profiles in the bGH mice and GH-/- mice (i.e. either upregulated or downregulated with both increased and decreased GH action). Interestingly, however, other bacteria, such as Parasutterella, Lachnospiraceae and Rikenellaceae, followed opposite trends between bGH and GH-/- mice (i.e. upregulated with increased GH action and downregulated with decreased GH action). Collectively, these results demonstrate that GH - in both states of excess and deficiency - yields a distinct microbial profile, including microbial abundance, diversity and potential function. More importantly, the common bacterial candidates like Parasutterella suggest that GH action influences the presence of certain gut microbiota. Additional studies will be conducted to further explore these unique GH-associated bacterial candidates and their impact on metabolic and intestinal health of the host. This work was partially funded by the John J. Kopchick Molecular and Cellular Biology/Translational Biomedical Sciences Research Fellowship, the Osteopathic Heritage Foundation, Dual Degree Program at Ohio University Heritage College of Osteopathic Medicine and the Mouse Metabolic Phenotyping Center at University of California, Davis (NIH grant U240DK092993).
- 1 March 2016
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 22, S74
P-214 A Study of Fecal Microbiota Transplantation in Pediatric Patients with Inflammatory Bowel Disease
- 1 March 2016
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 22, S74
P-214 A Study of Fecal Microbiota Transplantation in Pediatric Patients with Inflammatory Bowel Disease